{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:16:12Z","timestamp":1780568172001,"version":"3.54.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["R501-LR-RND003\\u20130000001319\\u20130000"],"award-info":[{"award-number":["R501-LR-RND003\\u20130000001319\\u20130000"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004595","name":"Universiti Sains Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2020\/TK0\/USM\/02\/32\\u20136171275"],"award-info":[{"award-number":["FRGS\/1\/2020\/TK0\/USM\/02\/32\\u20136171275"]}],"id":[{"id":"10.13039\/501100004595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajps.2025.101043","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:20:34Z","timestamp":1741983634000},"page":"101043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extracellular vesicles as delivery vehicles and therapeutic agents for glioblastoma treatment: A systematic review of in vitro and in vivo preclinical studies"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3610-8336","authenticated-orcid":false,"given":"Jun Quan","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6378-2447","authenticated-orcid":false,"given":"Nabil Ajwad","family":"Abu Yazid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0328-0023","authenticated-orcid":false,"given":"Shing Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9131-6937","authenticated-orcid":false,"given":"Tin Wui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2503-2338","authenticated-orcid":false,"given":"Si-Yuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2025.101043_bib0001","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/brainsci11010116","article-title":"Epidemiology of anthropometric factors in glioblastoma multiforme\u2014Literature review","volume":"11","author":"Simi\u0144ska","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.ajps.2025.101043_bib0002","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/cancers14092149","article-title":"Effectiveness of bioinks and the clinical value of 3D bioprinted glioblastoma models: a systematic review","volume":"14","author":"Leong","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0003","first-page":"e8195","article-title":"Rising incidence of glioblastoma multiforme in a well-defined population","volume":"12","author":"Grech","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ajps.2025.101043_bib0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40001-023-01011-y","article-title":"The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis","volume":"28","author":"Salari","year":"2023","journal-title":"Eur J Med Res"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0005","article-title":"Treatment options for recurrent glioblastoma: a network meta-analysis","volume":"2020","author":"Lawrie","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"10.1016\/j.ajps.2025.101043_bib0006","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA - J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai","year":"2008","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.ajps.2025.101043_bib0008","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/cancers14020443","article-title":"Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives","volume":"14","author":"Seker-Polat","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0009","first-page":"vdac156","article-title":"Factors affecting the radiation response in glioblastoma","volume":"4","author":"Aiyappa-Maudsley","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"11","key":"10.1016\/j.ajps.2025.101043_bib0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/brainsci13111536","article-title":"Advances in glioblastoma therapy: an update on current approaches","volume":"13","author":"Angom","year":"2023","journal-title":"Brain Sci"},{"issue":"19","key":"10.1016\/j.ajps.2025.101043_bib0011","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.3390\/ijms221910899","article-title":"Exosomes and brain metastases: a review on their role and potential applications","volume":"22","author":"Oliveira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2025.101043_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.733529","article-title":"The roles of exosomes as future therapeutic agents and diagnostic tools for glioma","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ajps.2025.101043_bib0013","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajps.2025.101043_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/life13040964","article-title":"Recent advancements on the use of exosomes as drug carriers for the treatment of glioblastoma","volume":"13","author":"Galardi","year":"2023","journal-title":"Life"},{"issue":"10","key":"10.1016\/j.ajps.2025.101043_bib0016","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cells12101416","article-title":"Current strategies for exosome cargo loading and targeting delivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ajps.2025.101043_bib0017","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","article-title":"Tumor-derived extracellular vesicles breach the intact blood\u2013brain barrier via transcytosis","volume":"13","author":"Morad","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0018","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","article-title":"Elucidation of exosome migration across the blood\u2013brain barrier model in vitro","volume":"9","author":"Chen","year":"2016","journal-title":"Cell Mol Bioeng"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0019","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/acs.molpharmaceut.8b00985","article-title":"Cluster of differentiation 46 is the major receptor in human blood\u2013brain barrier endothelial cells for uptake of exosomes derived from brain-metastatic elanoma cells (SK-Mel-28)","volume":"16","author":"Kuroda","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2025.101043_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110399","article-title":"Deciphering the relationship between caveolae-mediated intracellular transport and signalling events","volume":"97","author":"Popov","year":"2022","journal-title":"Cell Signal"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/cancers16040823","article-title":"Exosomes in glioma: unraveling their roles in progression, diagnosis, and therapy","volume":"16","author":"Yang","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajps.2025.101043_bib0022","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s13287-022-03212-4","article-title":"Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors","volume":"13","author":"Ghasempour","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ajps.2025.101043_bib0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12964-021-00760-9","article-title":"Extracellular vesicles derived from glioblastoma promote proliferation and migration of neural progenitor cells via PI3K-Akt pathway","volume":"20","author":"Pan","year":"2022","journal-title":"Cell Comm Signal"},{"key":"10.1016\/j.ajps.2025.101043_bib0024","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1538-7445.AM2023-3661","article-title":"Abstract 3661: extracellular vesicle derived from neural stem cells as potential vehicles of genetic information to modulate glioblastoma biology","volume":"83","author":"de Ara\u00fajo","year":"2023","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0025","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.3390\/ijms23052770","article-title":"Extracellular vesicles secreted by glioma stem cells are involved in radiation resistance and glioma progression","volume":"23","author":"Ma","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0026","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cells9051141","article-title":"The role of extracellular vesicles in the hallmarks of cancer and drug resistance","volume":"9","author":"Xavier","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mole Ther"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0028","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.ajps.2025.101043_bib0029","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio Rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.ajps.2025.101043_bib0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0031","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/pharmaceutics14010038","article-title":"Optimised electroporation for loading of extracellular vesicles with doxorubicin","volume":"14","author":"Lenna\u00e1rd","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ajps.2025.101043_bib0032","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/cancers14112632","article-title":"Dialogue among lymphocytes and microglia in glioblastoma microenvironment","volume":"14","author":"Mormino","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ajps.2025.101043_bib0033","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/RMR.0000000000000234","article-title":"Adult glioma WHO classification update, genomics, and imaging: what the radiologists need to know","volume":"29","author":"Bai","year":"2020","journal-title":"Topics Magnet Resonan Imaging"},{"key":"10.1016\/j.ajps.2025.101043_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122985","article-title":"Exosomes as targeted diagnostic biomarkers: recent studies and trends","volume":"354","author":"Marjani","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.ajps.2025.101043_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116201","article-title":"Canine glioblastoma-derived extracellular vesicles as precise carriers for glioblastoma imaging: targeting across the blood-brain barrier","volume":"172","author":"Villa","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajps.2025.101043_bib0036","first-page":"1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2016","journal-title":"Revista Espanola de Nutricion Humana y Dietetica"},{"key":"10.1016\/j.ajps.2025.101043_bib0037","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajps.2025.101043_bib0038","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2021.07.004","article-title":"Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: a head-to-head comparison","volume":"336","author":"Wu","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2025.101043_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135980","article-title":"Cancer-exocytosed exosomes loaded with bio-assembled AgNCs as smart drug carriers for targeted chemotherapy","volume":"440","author":"Tanziela","year":"2022","journal-title":"Chem Engineer J"},{"key":"10.1016\/j.ajps.2025.101043_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2025.101043_bib0041","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2017.09.022","article-title":"Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma","volume":"411","author":"Liu","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajps.2025.101043_bib0042","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy","volume":"345","author":"Rehman","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2025.101043_bib0043","article-title":"Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model","volume":"23","author":"Nooshabadi","year":"2020","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.ajps.2025.101043_bib0044","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.omtn.2021.12.029","article-title":"Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells","volume":"27","author":"Adamus","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajps.2025.101043_bib0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","article-title":"Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes","volume":"317","author":"Kim","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2025.101043_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112505","article-title":"Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment","volume":"215","author":"Wang","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ajps.2025.101043_bib0047","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2018.06.041","article-title":"Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype","volume":"433","author":"Yu","year":"2018","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.ajps.2025.101043_bib0048","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/mt.2011.164","article-title":"Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain","volume":"19","author":"Zhuang","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2025.101043_bib0049","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.omto.2020.12.006","article-title":"Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma in vitro and in vivo","volume":"20","author":"Wang","year":"2021","journal-title":"Mol Ther Oncolytics"},{"issue":"3","key":"10.1016\/j.ajps.2025.101043_bib0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/1061186X.2022.2152819","article-title":"Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme","volume":"31","author":"Rahmani","year":"2023","journal-title":"J Drug Target"},{"key":"10.1016\/j.ajps.2025.101043_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104385","article-title":"The anti-angiogenic effect of atorvastatin loaded exosomes on glioblastoma tumor cells: an in vitro 3D culture model","volume":"143","author":"Valipour","year":"2022","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ajps.2025.101043_bib0052","article-title":"Zinc sulfide-based hybrid exosome-coated nanoplatform for targeted treatment of glioblastoma in an orthotopic mouse glioblastoma model","volume":"17","author":"Liu","year":"2023","journal-title":"Mater Today Adv"},{"key":"10.1016\/j.ajps.2025.101043_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.144692","article-title":"Ginsenoside Rg3-engineered exosomes as effective delivery platform for potentiated chemotherapy and photoimmunotherapy of glioblastoma","volume":"471","author":"Li","year":"2023","journal-title":"Chem Engineering J"},{"key":"10.1016\/j.ajps.2025.101043_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154427","article-title":"Exosomes released from U87 glioma cells treated with curcumin and\/or temozolomide produce apoptosis in naive U87 cells","volume":"245","author":"Mousavi","year":"2023","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.ajps.2025.101043_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213388","article-title":"Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery","volume":"149","author":"Geng","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.ajps.2025.101043_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110754","article-title":"Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions","volume":"109","author":"Cheng","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.ajps.2025.101043_bib0057","article-title":"Bioinspired extracellular vesicle-coated silica nanoparticles as selective delivery systems","volume":"23","author":"Dumontel","year":"2023","journal-title":"Mater Today Bio"},{"issue":"2","key":"10.1016\/j.ajps.2025.101043_bib0058","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40199-019-00280-5","article-title":"Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques","volume":"27","author":"Salarpour","year":"2019","journal-title":"DARU, J Pharm Sci"},{"issue":"3","key":"10.1016\/j.ajps.2025.101043_bib0059","doi-asserted-by":"crossref","first-page":"e10203","DOI":"10.1002\/btm2.10203","article-title":"Doxorubicin-loaded nanoparticle coated with endothelial cells-derived exosomes for immunogenic chemotherapy of glioblastoma","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioeng Transl Med"},{"issue":"6","key":"10.1016\/j.ajps.2025.101043_bib0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801899","article-title":"Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv Sci"},{"issue":"8","key":"10.1016\/j.ajps.2025.101043_bib0061","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41417-023-00617-y","article-title":"Recent progress in exosome research: isolation, characterization and clinical applications","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0062","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1515\/tjb-2023-0086","article-title":"Exploring nanotechnology-based approaches using miRNAs to treat neurodegenerative disorders","volume":"48","author":"Mushtaq","year":"2023","journal-title":"Turkish J Biochem"},{"issue":"3","key":"10.1016\/j.ajps.2025.101043_bib0063","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1021\/acsnano.0c10689","article-title":"Microbubbles versus extracellular vesicles as therapeutic cargo for targeting drug delivery","volume":"15","author":"Ullah","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ajps.2025.101043_bib0064","doi-asserted-by":"crossref","first-page":"e10623","DOI":"10.1002\/btm2.10623","article-title":"Micro trojan horses: engineering extracellular vesicles crossing biological barriers for drug delivery","volume":"9","author":"Zeng","year":"2024","journal-title":"Bioeng Transl Med"},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0065","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/pharmaceutics15051439","article-title":"Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer","volume":"15","author":"Avgoulas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0066","first-page":"55","article-title":"Function of exosomes in neurological disorders and brain tumors. Extracell vesicles circ","volume":"2","author":"Xiao","year":"2021","journal-title":"Nucl Acids"},{"issue":"11","key":"10.1016\/j.ajps.2025.101043_bib0067","first-page":"3705","article-title":"Small extracellular vesicles in cancer","volume":"6","author":"Abhange","year":"2021","journal-title":"Bioact Mater"},{"issue":"10","key":"10.1016\/j.ajps.2025.101043_bib0068","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s13346-021-01087-1","article-title":"Exosomal targeting and its potential clinical application","volume":"12","author":"He","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.ajps.2025.101043_bib0069","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","article-title":"Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls","volume":"11","author":"Heidarzadeh","year":"2021","journal-title":"Cell Biosci"},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/cancers13051087","article-title":"Cellular and molecular mechanisms underlying glioblastoma and zebrafish models for the discovery of new treatments","volume":"13","author":"Reimunde","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0071","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0072","doi-asserted-by":"crossref","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0073","doi-asserted-by":"crossref","first-page":"e61515","DOI":"10.1371\/journal.pone.0061515","article-title":"Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells","volume":"8","author":"Jaiswal","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.ajps.2025.101043_bib0074","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.7150\/thno.27608","article-title":"Blood exosomes regulate the tissue distribution of grapefruit-derived nanovector via CD36 and IGFR1 pathways","volume":"8","author":"long","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2025.101043_bib0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.actbio.2017.05.013","article-title":"Augmented liver targeting of exosomes by surface modification with cationized pullulan","volume":"57","author":"Tamura","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2025.101043_bib0076","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1038\/srep10721","article-title":"Biodistribution and function of extracellular miRNA-155 in mice","volume":"5","author":"Bala","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0077","doi-asserted-by":"crossref","first-page":"26238","DOI":"10.3402\/jev.v4.26238","article-title":"Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice","volume":"4","author":"Imai","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0078","doi-asserted-by":"crossref","first-page":"42996","DOI":"10.1038\/srep42996","article-title":"Dendritic cells derived exosomes migration to spleen and induction of inflammation are regulated by CCR7","volume":"7","author":"Wei","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajps.2025.101043_bib0079","doi-asserted-by":"crossref","first-page":"e12085","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"10","key":"10.1016\/j.ajps.2025.101043_bib0080","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1002\/jex2.59","article-title":"Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina","volume":"1","author":"Driedonks","year":"2022","journal-title":"J Extracell Biol"},{"issue":"5","key":"10.1016\/j.ajps.2025.101043_bib0081","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/life12050618","article-title":"Extracellular vesicles and cell pathways involved in cancer chemoresistance","volume":"12","author":"Console","year":"2022","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0082","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/ijms15011392","article-title":"Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells","volume":"15","author":"Akao","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajps.2025.101043_bib0083","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.4049\/jimmunol.172.4.2137","article-title":"Exosomes as potent cell-free peptide-based vaccine. II. exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection","volume":"172","author":"Chaput","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ajps.2025.101043_bib0084","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/ijms18061122","article-title":"Engineering exosomes for cancer therapy","volume":"18","author":"Gilligan","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ajps.2025.101043_bib0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/25785826.2020.1818482","article-title":"Exosomes-based cell-free cancer therapy: a novel strategy for targeted therapy","volume":"44","author":"Dutta","year":"2021","journal-title":"Immunol Med"},{"issue":"51","key":"10.1016\/j.ajps.2025.101043_bib0086","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002440","article-title":"Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy","volume":"32","author":"Nam","year":"2020","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0087","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","article-title":"Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy","volume":"10","author":"Yong","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0088","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajps.2025.101043_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119925","article-title":"Bioinspired exosome-like therapeutics and delivery nanoplatforms","volume":"242","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0090","article-title":"Harnessing enucleated cancer cells as Trojan horse cell vaccines","volume":"5","author":"Fang","year":"2024","journal-title":"Cell Rep Phys Sci"},{"issue":"1","key":"10.1016\/j.ajps.2025.101043_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169899","article-title":"Reprogramming malignant cancer cells toward a benign phenotype following exposure to human embryonic stem cell microenvironment","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajps.2025.101043_bib0092","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2018.00018","article-title":"Exosome-based cell-cell communication in the tumor microenvironment","volume":"6","author":"Maia","year":"2018","journal-title":"Front Cell Dev Biol"},{"issue":"15","key":"10.1016\/j.ajps.2025.101043_bib0093","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.18632\/aging.102092","article-title":"Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2","volume":"11","author":"Yu","year":"2019","journal-title":"Aging (Albany NY)"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087625000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087625000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:40:43Z","timestamp":1778827243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087625000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1818087625000285"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2025.101043","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles as delivery vehicles and therapeutic agents for glioblastoma treatment: A systematic review of in vitro and in vivo preclinical studies","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2025.101043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101043"}}